• Guanabenz Acetate: Precision Tools for α2-Adrenergic Researc

  2026-07-15

  Guanabenz Acetate is redefining selective α2-adrenergic receptor agonism, enabling researchers to dissect GPCR signaling, stress granule formation, and innate immune pathways with unprecedented clarity. This guide delivers actionable workflows, troubleshooting strategies, and translational insights tailored to the highest standards of cellular and molecular research.

• Tubastatin A: HDAC6 Inhibitor Workflows for Cardiac & Cancer

  2026-07-15

  Tubastatin A, a highly selective HDAC6 inhibitor, unlocks targeted manipulation of cell death and inflammatory pathways in both cardiac injury and cancer models. Its robust selectivity and proven cardioprotective effects—most recently demonstrated in porcine resuscitation—make it a cornerstone reagent for translational disease modeling.

• FTO-Mediated m6A RNA Modification Drives Synovial Inflammati

  2026-07-14

  This study reveals that elevated FTO expression in rheumatoid arthritis (RA) synovial tissue enhances m6A RNA demethylation, stabilizing ADAMTS15 mRNA and promoting fibroblast-like synoviocyte (FLS) aggression and inflammation. Targeting FTO, either genetically or pharmacologically, suppressed these pathogenic processes and reduced arthritis severity, highlighting FTO as a promising therapeutic target in RA.

• Quercetin as a PI3K Inhibitor: Applied Workflows in Neuroinf

  2026-07-14

  Quercetin stands out as a high-purity PI3K inhibitor and apoptosis inducer, enabling researchers to probe anti-inflammatory and antineoplastic mechanisms across disease models. Recent advances demonstrate its value in neuroinflammation and depression assays, with robust protocols now supporting cross-domain translational workflows.

• HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L): Practical Guide

  2026-07-13

  HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody enables precise, high-sensitivity detection of rabbit primary antibodies in immunofluorescence, flow cytometry, and microscopy workflows. It is best used where signal amplification and minimal cross-reactivity are critical, but is not suitable for detection of non-rabbit primaries or in applications requiring direct antibody labeling.

• Bazedoxifene: Beyond Osteoporosis—A Cross-Domain SERM for Ad

  2026-07-13

  Explore Bazedoxifene as a selective estrogen receptor modulator with pioneering applications in both osteoporosis and antimalarial research. This article provides a deep mechanistic analysis and bridges domains to guide next-generation assay development.

• DPPH Radical Assay: Applied Workflows for Antioxidant Screen

  2026-07-12

  DPPH (2,2-Diphenyl-1-Picrylhydrazyl) Radical delivers reproducible, colorimetric in vitro antioxidant screening for natural products, extracts, and drug candidates. Here, we break down real-world assay optimizations, highlight innovations from comparative Taihangia rupestris research, and provide troubleshooting strategies for maximizing assay reliability.

• Orientia tsutsugamushi Modulates RIPK3 but Not Necroptosis

  2026-07-10

  This study demonstrates that Orientia tsutsugamushi reduces cellular RIPK3 levels via its ankyrin repeat effectors but does not inhibit necroptosis once triggered. These findings clarify pathogen strategies for programmed cell death evasion and highlight differences from viral mechanisms, informing experimental approaches to cell death and host-pathogen interactions.

• Dehydroepiandrosterone (DHEA): Protocols for Neuroprotection

  2026-07-09

  Dehydroepiandrosterone (DHEA) offers a validated edge in research targeting neuroprotection, apoptosis inhibition, and granulosa cell proliferation. This guide translates bench-proven workflows and troubleshooting insights into actionable strategies using APExBIO's DHEA.

• Triiodothyronine (T3) for Metabolic Assays: Protocols & Prec

  2026-07-09

  Triiodothyronine (T3) from APExBIO delivers high-purity, reproducible performance in metabolic and thyroid hormone signaling assays. This article details advanced workflows, troubleshooting strategies, and the practical impact of recent innovations in gene editing models.

• Predicting Major Bleeding Risk in Extended VTE Anticoagulati

  2026-07-08

  The referenced study introduces and validates the CHAP model, a simplified clinical tool for predicting major bleeding during extended anticoagulation in unprovoked or weakly provoked venous thromboembolism (VTE). This model is compared with established risk scores, offering researchers and clinicians an evidence-based approach to risk stratification and treatment duration decisions.

• Chloramphenicol in Modern Plasmid Assays: Precision, Resista

  2026-07-08

  Explore the multifaceted roles of chloramphenicol in contemporary molecular biology, from its mechanistic action as a bacterial protein synthesis inhibitor to its strategic use in high-stringency plasmid selection assays. This article uniquely connects recent resistance gene dynamics to practical assay optimization.

• Stiripentol as an LDH Inhibitor: Workflows for Metabolic Res

  2026-07-07

  Stiripentol, a novel LDH inhibitor, uniquely enables targeted modulation of the astrocyte-neuron lactate shuttle, supporting advanced epilepsy and immunometabolic research workflows. This article details robust protocol parameters, practical troubleshooting, and the translational impact of lactate metabolism modulation illuminated by recent literature.

• Telomere Recapping Restores Cardiac Function via Nuclear–Mit

  2026-07-07

  This study demonstrates that engineered telomere recapping using a catalytically inactive telomerase variant halts pathological telomere-to-mitochondrial DNA signaling in heart failure, restoring mitochondrial homeostasis and cardiac function. The findings establish telomere protection as a central regulator of nuclear–mitochondrial crosstalk and reveal actionable targets for heart failure therapy.

• Quizartinib (AC220): Precision FLT3 Inhibition for AML Model

  2026-07-06

  Quizartinib (AC220) delivers unmatched selectivity and potency for FLT3 inhibition, empowering acute myeloid leukemia research with reproducible, translational workflows. This guide details optimized protocols, troubleshooting strategies, and real-world applications, equipping researchers to model resistance and interrogate FLT3 signaling with confidence.

447 records 11/30 page Previous Next First page 上5页 1112131415 下5页 Last page